ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕

Name

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

URL

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

go to the article

go back to the homepage

Subscription
Newsletter
Advertising

Latest news
Background
Opinion
The Mag
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

Tag Archive for: KOL oncologists

Nothing Found

Sorry, no posts matched your criteria

LATEST NEWS

owkin spin out waiv

Owkin spins out AI diagnostics startup Waiv with $3...

ADC linker technology by Valanx Biotech from Vienna

Vienna’s VALANX secures €3 million to push prec...

Enodia protein degradation

Enodia strikes up to $127m deal for Kezar’s precl...

ADVERTISEMENT

MAGAZINE

1 / 4

EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

2 / 4

EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

3 / 4

01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

4 / 4

EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

SPONSORED PUBLICATION

BioDlink heaquarters Suzhou

Drug development

Solutions-Based Thinking: BioDlink’s Model for Successful CDMO Partnerships

In an interview with European Biotechnology Magazine during J.P. Morgan Week in San Francisco, Dr. Jian Zhang, Acting CEO of BioDlink, explains how a partnership-first approach and deep ADC expertise … more ➔

newsletter_link

Knowbio GmbH

Link to LinkedIn
Link to Instagram

Contact
Imprint
Privacy policy